You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 426 ES005, a high affinity anti-LAG3 monoclonal antibody, inhibits the interactions between LAG3 and multiple ligands and enhances anti-tumor activity of T cells in preclinical models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
426 ES005, a high affinity anti-LAG3 monoclonal antibody, inhibits the interactions between LAG3 and multiple ligands and enhances anti-tumor activity of T cells in preclinical models
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to August 2024

AbstractFullPdf
Nov 2022235020
Dec 202260010
Jan 20233400
Feb 20234005
Mar 20233202
Apr 20234204
May 20232802
Jun 20231601
Jul 20231804
Aug 20232203
Sep 2023402
Oct 20233402
Nov 20232602
Dec 20239804
Jan 2024601
Feb 20242602
Mar 20242605
Apr 202430011
May 20242601
Jun 20242401
Jul 20243403
Aug 20243002
Total891087